Intarcia Therapeutics Statistics and Facts (2022)

Last Updated on: August 3rd, 2022

Intarcia Therapeutics Statistics and Facts 2022

Here are a few of the most interesting Intarcia Therapeutics statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.

Intarcia Therapeutics Facts

Here is pretty much everything you ever wanted to know about Intarcia Therapeutics.

  • Website: Official Website
  • Year Founded: 1997
  • Headquarters: Boston, MA
  • Founder(s): David Franklin, James M. Ahlers, Thomas Alessi
  • Current Chief Executive: Kurt C. Graves

What is Intarcia Therapeutics?

Intarcia is a rapidly growing biopharmaceutical company developing innovative therapies that merge medicine and technology. We seek to transform the standard of care and improve patient outcomes in major therapeutic categories for serious chronic diseases, such as diabetes. (source)

Additional Intarcia Therapeutics Statistics

Reported amount Intarcia Therapeutics is valued at:

$4.11 billion

Last updated 8/17/18

Amount Intarcia Therapeutics has raised to date:

$1.4 billion

Last updated 8/17/18

Please note that some of these numbers are easier to find than others. A few of these Intarcia Therapeutics statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.

Related Categories:

All Stats and Fun Facts, Biotech Statistics, Health Care Statistics

Related Tags:


About Craig Smith

DMR Publisher. Director of Marketing by day and I run this little site at night. Other interests include Disney, Sports, 80's Nostalgia, LEGO, Star Wars and Tech Gadgets. Other sites include and